{"entity":{"type":"insider","cik":"0001685532","url":"/insider/0001685532","json_url":"/insider/0001685532.json","name":"Silver Gabrielle Alison","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":4,"first":"2019-11-25","last":"2022-05-17","span_basis":"filed_date"},"name_variants":[{"name":"Silver Gabrielle Alison","source":"filing","n_filings":4,"first_seen":"2019-11-25","last_seen":"2022-05-17"}],"transactions":[{"id":6408926,"accession":"0001385508-22-000062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-22-000062","line_url":"/filing/0001385508-22-000062#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001685532","owner_name":"Silver Gabrielle Alison","owner_display_name":"Silver Gabrielle Alison","owner_url":"/insider/0001685532","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":13.288,"price_display":"13.29","price_state":"stated","total_value":33220.0,"total_display":"33,220.00","total_whole":"33,220","shares_owned_after":21343.0,"shares_owned_after_display":"21,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-17","scope":"insider"},{"id":5180123,"accession":"0001385508-21-000045","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001385508-21-000045","line_url":"/filing/0001385508-21-000045#line-6","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001685532","owner_name":"Silver Gabrielle Alison","owner_display_name":"Silver Gabrielle Alison","owner_url":"/insider/0001685532","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7157.0,"shares_display":"7,157","price_per_share":11.07,"price_display":"11.07","price_state":"stated","total_value":79227.99,"total_display":"79,227.99","total_whole":"79,228","shares_owned_after":16478.0,"shares_owned_after_display":"16,478","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-17","filed_date":"2021-03-17","scope":"insider"},{"id":5180114,"accession":"0001385508-21-000045","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001385508-21-000045","line_url":"/filing/0001385508-21-000045#line-4","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001685532","owner_name":"Silver Gabrielle Alison","owner_display_name":"Silver Gabrielle Alison","owner_url":"/insider/0001685532","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1949.0,"shares_display":"1,949","price_per_share":11.5,"price_display":"11.50","price_state":"stated","total_value":22413.5,"total_display":"22,413.50","total_whole":"22,414","shares_owned_after":15749.0,"shares_owned_after_display":"15,749","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-16","filed_date":"2021-03-17","scope":"insider"},{"id":5180107,"accession":"0001385508-21-000045","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-21-000045","line_url":"/filing/0001385508-21-000045#line-2","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001685532","owner_name":"Silver Gabrielle Alison","owner_display_name":"Silver Gabrielle Alison","owner_url":"/insider/0001685532","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":11.64,"price_display":"11.64","price_state":"stated","total_value":45396.0,"total_display":"45,396.00","total_whole":"45,396","shares_owned_after":15467.0,"shares_owned_after_display":"15,467","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-17","scope":"insider"},{"id":3333125,"accession":"0001385508-20-000069","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-20-000069","line_url":"/filing/0001385508-20-000069#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001685532","owner_name":"Silver Gabrielle Alison","owner_display_name":"Silver Gabrielle Alison","owner_url":"/insider/0001685532","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2730.0,"shares_display":"2,730","price_per_share":9.13,"price_display":"9.13","price_state":"stated","total_value":24924.9,"total_display":"24,924.90","total_whole":"24,925","shares_owned_after":4515.0,"shares_owned_after_display":"4,515","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-10","filed_date":"2020-06-12","scope":"insider"},{"id":8363984,"accession":"0001385508-19-000119","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-19-000119","line_url":"/filing/0001385508-19-000119#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001685532","owner_name":"Silver Gabrielle Alison","owner_display_name":"Silver Gabrielle Alison","owner_url":"/insider/0001685532","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1785.0,"shares_display":"1,785","price_per_share":13.51,"price_display":"13.51","price_state":"stated","total_value":24115.35,"total_display":"24,115.35","total_whole":"24,115","shares_owned_after":1785.0,"shares_owned_after_display":"1,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-22","filed_date":"2019-11-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001385508","name":"OPIANT PHARMACEUTICALS, INC.","url":"/issuer/0001385508","role":"Director","n_filings":4,"first_seen":"2019-11-25","last_seen":"2022-05-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001685532","retrieved_at":"2026-08-24T19:13:21+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}